Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doravirine Dose Optimisation in Pregnancy
NCT05630638Phase 4Recruiting
- Sponsor
- University of Liverpool
- Start
- Oct 2023
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doravirine in human immunodeficiency virus infection (HIV), sponsored by University of Liverpool. Started Oct 2023; status: recruiting.
02
Drugs
doravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05630638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05630638.